Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-80
SponsorLovisenberg Diakonale Hospital
About this trial
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Eligibility criteria
Qualifiers
Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
Able to read or write Norwegian
Disqualifiers
Severe osteoporosis
Osteonecrosis of the humeral head
Dementia
Poor deltoid function
Trial design
Treatments tested in this trial
- BIO-RSA
- RSA
Treatment groups
130 Participants
are divided into 2 treatment groupsLocations
2Sykehuset Telemark HF3710, SkienTelemark, Norway
Lovisenberg Diaconal Hospital0456, Oslo Norway
Sponsors and collaborators
Lovisenberg Diakonale Hospital
Lead sponsor
Haukeland University Hospital
Collaborator
Sykehuset Telemark
Collaborator
University Hospital, Akershus
Collaborator
Source ClinicalTrials.gov